FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileBaxter International Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
BAX
Baxter International Inc. Stock AnalysisComprehensive stock analysis for Baxter International Inc. (BAX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisBAX
BAX
Baxter International Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
BAX
  1. Home
  2. Stocks
  3. Baxter International Inc.

Baxter International Inc.

🇺🇸BAX•NYSE

Baxter International Inc.

🇺🇸BAX•NYSE
Market cap
$13.21B
Sentiment

Your view on BAX

Mkt Cap
$13.21B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Baxter International Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Andrew P. Hider
Headquarters
One Baxter Parkway, Deerfield, IL, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Andrew P. Hider
Headquarters
One Baxter Parkway, Deerfield, IL, US
Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.

The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.

It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.

In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision.

The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules.

Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Baxter International Inc. from FRC's valuation model, read against the market price. BAX last traded at $25.54; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Baxter International Inc.. Starting points for Baxter International Inc.: EPS -$1.40, beta 0.67 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Baxter International Inc.. Baxter International Inc. paid $0.04 per share over the last year — a 0.2% yield at the current $25.54 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Baxter International Inc.. Trailing twelve-month EPS for Baxter International Inc. stands at -$1.40. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$22.25

average of 8 firms, last 12 months

 

$22.25

Low $15.00

Median $22.50

High $28.00

 

Analyst Ratings

Hold10 firms, last 12 months
  • Strong Buy0
  • Buy1
  • Hold7
  • Sell2
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$0.60$0.41$2.11$2.04
Low estimate$0.59$0.38$2.06$1.75
High estimate$0.61$0.43$2.13$2.13
No. of analysts1061010
Year-ago EPS$0.44$0.36-$1.751—
Growth+35.6%+14.8%——

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$3.09B$2.76B$11.72B$11.97B
Low estimate$3.05B$2.74B$11.61B$11.77B
High estimate$3.10B$2.78B$11.75B$12.04B
No. of analysts951111
Year-ago revenue$2.97B$2.70B$11.24B—
Growth+3.8%+2.3%+4.3%—
Recent analyst actions15 rating and price-target changes, latest Nov 9, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Baxter International Inc.. Baxter International Inc. has reported as a listed company since 1981. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold BAX17 companies · 8 funds
Compare BAX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • DVADaVita Inc.Medical - Care Facilities$11.0B
  • FMSFresenius Medical Care AG & Co. KGaAMedical - Care Facilities$11.7B
  • ICUIICU Medical, Inc.Medical - Instruments & Supplies$4.5B
  • INFUInfuSystem Holdings, Inc.Medical - Devices$296M
  • RMTIRockwell Medical, Inc.Drug Manufacturers - Specialty & Generic$27M

More Medical - Instruments & Supplies companies

  • MHUAFMeihua International Medical Technologies Co., Ltd.OTC$6M
  • MLSSMilestone Scientific Inc.AMEX$27M
  • MMSIMerit Medical Systems, Inc.NASDAQ$5.2B
  • NAN.AXNanosonics LimitedASX
  • NEPHNephros, Inc.NASDAQ$33M
  • NNCSFNanosonics LimitedOTC$698M
  • NNNNAnbio Biotechnology Class A Ordinary SharesNASDAQ$170M
  • NPRRFNipro CorporationOTC$1.3B
  • NVSTEnvista Holdings CorpNYSE$3.9B
  • NXGLNEXGEL, Inc.NASDAQ$2M
  • NXGLWNEXGEL, Inc.NASDAQ$504,035
  • OJSYOJsys, Inc.OTC$454,285

ETFs holding Baxter International Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.02%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.02%
  • VBVanguard Small-Cap ETF$76.9B in assets0.15%
  • RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.21%
  • PZLVPzena U.S. Large Cap Value ETF$71M in assets5.00%
  • ADPVAdaptiv Select ETF$173M in assets3.94%
  • IHIiShares US Medical Devices ETF$4.0B in assets1.68%
  • FPAGFPA Global Equity ETF$673M in assets1.54%

Largest holders first, then the funds most concentrated in BAX.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Baxter International Inc., and how their positions are changing. At a $13.21B market value, institutional positions materially move Baxter International Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Baxter International Inc. executives and directors. Shares of Baxter International Inc. have traded between $17.40 and $37.74 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Baxter International Inc.. Baxter International Inc. is a $13.21B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Baxter International Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Baxter International Inc.. Coverage tracks Baxter International Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Baxter International Inc.

BAX Analysis
Fair
Past4
Growth2
Health3
Profit1
Value1

News

Latest Market News